Wealth Science Advisors’s Johnson & Johnson JNJ Stock Holding History

Wealth Science Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-59	Closed	-$12.2K	–	155
2026 Q1	$12.2K	Buy	+59	New	+$13.7K	0.01%	135

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wealth Science Advisors's JNJ Position: Q2 2026 in Review

Wealth Science Advisors sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 59 shares — an estimated $12.2K sold.

Wealth Science Advisors first reported a position in JNJ in Q1 2026 and held it in 1 quarter. The position peaked at $12.2K in Q1 2026. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Wealth Science Advisors reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
Wealth Science Advisors sold 59 Johnson & Johnson shares in Q2 2026, an estimated $12.2K.
Wealth Science Advisors first reported a position in Johnson & Johnson in Q1 2026 and held it in 1 quarter.
Wealth Science Advisors's Johnson & Johnson position peaked at $12.2K in Q1 2026.
4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Wealth Science Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.